Late-stage, primary open-angle glaucoma in Europe

social and health care maintenance costs and quality of life of patients from 4 countries

J Thygesen, M Aagren, S Arnavielle, A Bron, S J Fröhlich, K Baggesen, A Azuara-Blanco, P Buchholz, J G Walt

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

OBJECTIVE: The purpose of this study was to estimate costs and quality of life (QoL) of late-stage glaucoma patients in 4 European countries. METHODS: Retrospective review of medical charts of patients with POAG who were followed in a low-vision or vision rehabilitation center in one of 4 countries for at least 1 year was used to determine patient characteristics, health status, and health care resource use. Visual impairment was measured by best-corrected visual acuity (Snellen score). Patients were also interviewed over the telephone in order to assess their health-related QoL (using EuroQol EQ-5D) and use of resources including: the number of visits to rehabilitation centers, visits to hospital and non-hospital specialists, the use of low-vision devices, medication, tests, and the use of hired home help. The costs associated with resource use were calculated from the perspective of a third-party payer of health and social care based on resource usage and unit costs in each country. RESULTS: Patients undergoing visual rehabilitation in France (n=21), Denmark (n=59), Germany (n=60), and the United Kingdom (n=22) were identified, interviewed and had their medical charts reviewed. Annual maintenance costs of late-stage glaucoma amounted to euro830 (+/-445) on average. Average home help costs were more than 3 times higher. QoL, on average, was 0.65 (+/-0.28). QoL was positively correlated with the level of visual acuity in the patients' best eye. On the other hand, visual acuity was also positively correlated to health care costs, but negatively correlated to costs of home help. CONCLUSIONS: The study was limited by its observational, uncontrolled design. The finding that late-stage glaucoma is associated with higher home help costs than health care maintenance costs suggests that potential savings from a better preventive treatment are to be found for social care payers rather than health care payers.
Original languageEnglish
Pages (from-to)1763-1770
Number of pages8
JournalCurrent Medical Research and Opinion
Volume24
Issue number6
DOIs
Publication statusPublished - 1 Jun 2008

Fingerprint

Health Care Costs
Maintenance
Quality of Life
Costs and Cost Analysis
Glaucoma
Visual Acuity
Low Vision
Rehabilitation Centers
Delivery of Health Care
Health Insurance Reimbursement
Health Resources
Vision Disorders
Denmark
Primary Open Angle Glaucoma
Telephone
Health Status
France
Germany
Rehabilitation
Equipment and Supplies

Keywords

  • Aged
  • Aged, 80 and over
  • Cost of Illness
  • Europe
  • Female
  • Glaucoma
  • Health Expenditures
  • Health Services
  • Health Status
  • Humans
  • Interviews as Topic
  • Male
  • Medical Audit
  • Middle Aged
  • Quality of Life
  • Retrospective Studies
  • Self-Help Devices

Cite this

Late-stage, primary open-angle glaucoma in Europe : social and health care maintenance costs and quality of life of patients from 4 countries. / Thygesen, J; Aagren, M; Arnavielle, S; Bron, A; Fröhlich, S J; Baggesen, K; Azuara-Blanco, A; Buchholz, P; Walt, J G.

In: Current Medical Research and Opinion, Vol. 24, No. 6, 01.06.2008, p. 1763-1770.

Research output: Contribution to journalArticle

Thygesen, J, Aagren, M, Arnavielle, S, Bron, A, Fröhlich, SJ, Baggesen, K, Azuara-Blanco, A, Buchholz, P & Walt, JG 2008, 'Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries', Current Medical Research and Opinion, vol. 24, no. 6, pp. 1763-1770. https://doi.org/10.1185/03007990802111068
Thygesen, J ; Aagren, M ; Arnavielle, S ; Bron, A ; Fröhlich, S J ; Baggesen, K ; Azuara-Blanco, A ; Buchholz, P ; Walt, J G. / Late-stage, primary open-angle glaucoma in Europe : social and health care maintenance costs and quality of life of patients from 4 countries. In: Current Medical Research and Opinion. 2008 ; Vol. 24, No. 6. pp. 1763-1770.
@article{5a65023d56974c7bb78c596b1a4376ec,
title = "Late-stage, primary open-angle glaucoma in Europe: social and health care maintenance costs and quality of life of patients from 4 countries",
abstract = "OBJECTIVE: The purpose of this study was to estimate costs and quality of life (QoL) of late-stage glaucoma patients in 4 European countries. METHODS: Retrospective review of medical charts of patients with POAG who were followed in a low-vision or vision rehabilitation center in one of 4 countries for at least 1 year was used to determine patient characteristics, health status, and health care resource use. Visual impairment was measured by best-corrected visual acuity (Snellen score). Patients were also interviewed over the telephone in order to assess their health-related QoL (using EuroQol EQ-5D) and use of resources including: the number of visits to rehabilitation centers, visits to hospital and non-hospital specialists, the use of low-vision devices, medication, tests, and the use of hired home help. The costs associated with resource use were calculated from the perspective of a third-party payer of health and social care based on resource usage and unit costs in each country. RESULTS: Patients undergoing visual rehabilitation in France (n=21), Denmark (n=59), Germany (n=60), and the United Kingdom (n=22) were identified, interviewed and had their medical charts reviewed. Annual maintenance costs of late-stage glaucoma amounted to euro830 (+/-445) on average. Average home help costs were more than 3 times higher. QoL, on average, was 0.65 (+/-0.28). QoL was positively correlated with the level of visual acuity in the patients' best eye. On the other hand, visual acuity was also positively correlated to health care costs, but negatively correlated to costs of home help. CONCLUSIONS: The study was limited by its observational, uncontrolled design. The finding that late-stage glaucoma is associated with higher home help costs than health care maintenance costs suggests that potential savings from a better preventive treatment are to be found for social care payers rather than health care payers.",
keywords = "Aged, Aged, 80 and over, Cost of Illness, Europe, Female, Glaucoma, Health Expenditures, Health Services, Health Status, Humans, Interviews as Topic, Male, Medical Audit, Middle Aged, Quality of Life, Retrospective Studies, Self-Help Devices",
author = "J Thygesen and M Aagren and S Arnavielle and A Bron and Fr{\"o}hlich, {S J} and K Baggesen and A Azuara-Blanco and P Buchholz and Walt, {J G}",
year = "2008",
month = "6",
day = "1",
doi = "10.1185/03007990802111068",
language = "English",
volume = "24",
pages = "1763--1770",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Late-stage, primary open-angle glaucoma in Europe

T2 - social and health care maintenance costs and quality of life of patients from 4 countries

AU - Thygesen, J

AU - Aagren, M

AU - Arnavielle, S

AU - Bron, A

AU - Fröhlich, S J

AU - Baggesen, K

AU - Azuara-Blanco, A

AU - Buchholz, P

AU - Walt, J G

PY - 2008/6/1

Y1 - 2008/6/1

N2 - OBJECTIVE: The purpose of this study was to estimate costs and quality of life (QoL) of late-stage glaucoma patients in 4 European countries. METHODS: Retrospective review of medical charts of patients with POAG who were followed in a low-vision or vision rehabilitation center in one of 4 countries for at least 1 year was used to determine patient characteristics, health status, and health care resource use. Visual impairment was measured by best-corrected visual acuity (Snellen score). Patients were also interviewed over the telephone in order to assess their health-related QoL (using EuroQol EQ-5D) and use of resources including: the number of visits to rehabilitation centers, visits to hospital and non-hospital specialists, the use of low-vision devices, medication, tests, and the use of hired home help. The costs associated with resource use were calculated from the perspective of a third-party payer of health and social care based on resource usage and unit costs in each country. RESULTS: Patients undergoing visual rehabilitation in France (n=21), Denmark (n=59), Germany (n=60), and the United Kingdom (n=22) were identified, interviewed and had their medical charts reviewed. Annual maintenance costs of late-stage glaucoma amounted to euro830 (+/-445) on average. Average home help costs were more than 3 times higher. QoL, on average, was 0.65 (+/-0.28). QoL was positively correlated with the level of visual acuity in the patients' best eye. On the other hand, visual acuity was also positively correlated to health care costs, but negatively correlated to costs of home help. CONCLUSIONS: The study was limited by its observational, uncontrolled design. The finding that late-stage glaucoma is associated with higher home help costs than health care maintenance costs suggests that potential savings from a better preventive treatment are to be found for social care payers rather than health care payers.

AB - OBJECTIVE: The purpose of this study was to estimate costs and quality of life (QoL) of late-stage glaucoma patients in 4 European countries. METHODS: Retrospective review of medical charts of patients with POAG who were followed in a low-vision or vision rehabilitation center in one of 4 countries for at least 1 year was used to determine patient characteristics, health status, and health care resource use. Visual impairment was measured by best-corrected visual acuity (Snellen score). Patients were also interviewed over the telephone in order to assess their health-related QoL (using EuroQol EQ-5D) and use of resources including: the number of visits to rehabilitation centers, visits to hospital and non-hospital specialists, the use of low-vision devices, medication, tests, and the use of hired home help. The costs associated with resource use were calculated from the perspective of a third-party payer of health and social care based on resource usage and unit costs in each country. RESULTS: Patients undergoing visual rehabilitation in France (n=21), Denmark (n=59), Germany (n=60), and the United Kingdom (n=22) were identified, interviewed and had their medical charts reviewed. Annual maintenance costs of late-stage glaucoma amounted to euro830 (+/-445) on average. Average home help costs were more than 3 times higher. QoL, on average, was 0.65 (+/-0.28). QoL was positively correlated with the level of visual acuity in the patients' best eye. On the other hand, visual acuity was also positively correlated to health care costs, but negatively correlated to costs of home help. CONCLUSIONS: The study was limited by its observational, uncontrolled design. The finding that late-stage glaucoma is associated with higher home help costs than health care maintenance costs suggests that potential savings from a better preventive treatment are to be found for social care payers rather than health care payers.

KW - Aged

KW - Aged, 80 and over

KW - Cost of Illness

KW - Europe

KW - Female

KW - Glaucoma

KW - Health Expenditures

KW - Health Services

KW - Health Status

KW - Humans

KW - Interviews as Topic

KW - Male

KW - Medical Audit

KW - Middle Aged

KW - Quality of Life

KW - Retrospective Studies

KW - Self-Help Devices

U2 - 10.1185/03007990802111068

DO - 10.1185/03007990802111068

M3 - Article

VL - 24

SP - 1763

EP - 1770

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 6

ER -